Literature DB >> 7960139

Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.

D C Kaslow1, I C Bathurst, T Lensen, T Ponnudurai, P J Barr, D B Keister.   

Abstract

Antibodies to Pfs25, a cysteine-rich 25-kDa protein present on the surface of Plasmodium falciparum zygotes, can completely block the transmission of malaria parasites when mixed with infectious blood and fed to mosquitoes through a membrane feeding apparatus. Recently, a polypeptide analog, Pfs25-B, secreted from recombinant Saccharomyces cerevisiae was found to react with conformation-dependent, transmission-blocking monoclonal antibodies and to elicit transmission-blocking antibodies in experimental animals when emulsified in either Freund's or muramyl tripeptide adjuvant. In this study, Pfs25-B adsorbed to alum induced transmission-blocking antibodies in both rodents and primates. Bacterially produced Pfs25, however, did not elicit complete transmission-blocking antibodies in rodents. Furthermore, unlike monoclonal antibodies to Pfs25, which block transmission only after ookinete development, antisera to Pfs25-B adsorbed to alum appeared to block the in vivo development of zygotes to ookinetes as well.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7960139      PMCID: PMC303304          DOI: 10.1128/iai.62.12.5576-5580.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes.

Authors:  T Ponnudurai; A H Lensen; G J Van Gemert; M P Bensink; M Bolmer; J H Meuwissen
Journal:  Parasitology       Date:  1989-04       Impact factor: 3.234

2.  Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures.

Authors:  A N Vermeulen; J van Deursen; R H Brakenhoff; T H Lensen; T Ponnudurai; J H Meuwissen
Journal:  Mol Biochem Parasitol       Date:  1986-08       Impact factor: 1.759

3.  The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes.

Authors:  K P Sieber; M Huber; D Kaslow; S M Banks; M Torii; M Aikawa; L H Miller
Journal:  Exp Parasitol       Date:  1991-02       Impact factor: 2.011

Review 4.  Transmission-blocking immunity against malaria and other vector-borne diseases.

Authors:  D C Kaslow
Journal:  Curr Opin Immunol       Date:  1993-08       Impact factor: 7.486

5.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

6.  A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.

Authors:  C A Grotendorst; N Kumar; R Carter; D C Kaushal
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.

Authors:  D C Kaslow; I A Quakyi; C Syin; M G Raum; D B Keister; J E Coligan; T F McCutchan; L H Miller
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

8.  Genetic analysis of the human malaria parasite Plasmodium falciparum.

Authors:  D Walliker; I A Quakyi; T E Wellems; T F McCutchan; A Szarfman; W T London; L M Corcoran; T R Burkot; R Carter
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

9.  Research toward malaria vaccines.

Authors:  L H Miller; R J Howard; R Carter; M F Good; V Nussenzweig; R S Nussenzweig
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

10.  Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.

Authors:  A N Vermeulen; T Ponnudurai; P J Beckers; J P Verhave; M A Smits; J H Meuwissen
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  57 in total

1.  Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.

Authors:  L Wang; C G Black; V M Marshall; R L Coppel
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies.

Authors:  C A Lobo; R Dhar; N Kumar
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies.

Authors:  A W Stowers; D B Keister; O Muratova; D C Kaslow
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.

Authors:  Ralph LeBlanc; Yessika Vasquez; Drew Hannaman; Nirbhay Kumar
Journal:  Vaccine       Date:  2007-11-20       Impact factor: 3.641

Review 5.  Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.

Authors:  Ajay K Saxena; Yimin Wu; David N Garboczi
Journal:  Eukaryot Cell       Date:  2007-06-08

6.  Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.

Authors:  Cevayir Coban; Ken J Ishii; Anthony W Stowers; David B Keister; Dennis M Klinman; Nirbhay Kumar
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.

Authors:  Cevayir Coban; Mario T Philipp; Jeanette E Purcell; David B Keister; Mobolaji Okulate; Dale S Martin; Nirbhay Kumar
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

Authors:  T Tsuboi; D C Kaslow; M M Gozar; M Tachibana; Y M Cao; M Torii
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

9.  A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.

Authors:  R Mark Jones; Jessica A Chichester; Slobodanka Manceva; Sandra K Gibbs; Konstantin Musiychuk; Moneim Shamloul; Joey Norikane; Stephen J Streatfield; Marga van de Vegte-Bolmer; Will Roeffen; Robert W Sauerwein; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.

Authors:  Yue Qiu; Yan Zhao; Fei Liu; Bo Ye; Zhenjun Zhao; Sataporn Thongpoon; Wanlapa Roobsoong; Jetsumon Sattabongkot; Liwang Cui; Qi Fan; Yaming Cao
Journal:  Vaccine       Date:  2020-02-21       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.